Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors

BMC Cancer

Volumn 10, Issue , 2010, Pages

  del Rey, Javier ^a   Prat, Esther ^a   Ponsa, Immaculada ^a   Lloreta, Josep ^b   Gelabert, Antoni ^c   Algaba, Ferran ^a   Camps, Jordi ^a,d   Miró, Rosa ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; CYCLIN D1; GAMMA TUBULIN; PARAFFIN; CCND1 PROTEIN, HUMAN; TUBULIN; TUMOR MARKER;

ANEUPLOIDY; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER RECURRENCE; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME 11; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOUBLE MINUTE CHROMOSOME; EMBEDDING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVERALL SURVIVAL; ADULT; AGED; BLADDER TUMOR; CANCER STAGING; CHEMISTRY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MALE; MICRONUCLEUS; MIDDLE AGED; MITOSIS; MORTALITY; PATHOLOGY; PROGNOSIS; TIME;

ADULT; AGED; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN D1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIERS ESTIMATE; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED; MITOSIS; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; TIME FACTORS; TUBULIN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77953306057     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-280     Document Type: Article

References (43)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
2. Fadl-Elmula I. Chromosomal changes in uroepithelial carcinomas. Cell Chromosome 2005, 4:1. 10.1186/1475-9268-4-1, 1199610, 16083510.
3. Prat E, Bernues M, Caballin MR, Egozcue J, Gelabert A, Miro R. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology 2001, 57:986-992. 10.1016/S0090-4295(01)00909-8, 11337313.
4. Bringuier PP, Tamimi Y, Schuuring E, Schalken J. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 1996, 12:1747-1753.
5. Ewen ME, Lamb J. The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med 2004, 10:158-162. 10.1016/j.molmed.2004.02.005, 15059606.
6. Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Hering F, et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 2003, 201:603-608. 10.1002/path.1481, 14648664.
7. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays 1998, 20:473-479. 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.0.CO;2-N, 9699459.
8. Roelofs H, Schuuring E, Wiegant J, Michalides R, Giphart-Gassler M. Amplification of the 11q13 region in human carcinoma cell lines: a mechanistic view. Genes Chromosomes Cancer 1993, 7:74-84. 10.1002/gcc.2870070203, 7687456.
9. Moreau LA, McGrady P, London WB, Shimada H, Cohn SL, Maris JM, Diller L, Look AT, George RE. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study. Clin Cancer Res 2006, 12:5693-5697. 10.1158/1078-0432.CCR-06-1500, 17020972.
10. O'Neill S, Ekstrom L, Lastowska M, Roberts P, Brodeur GM, Kees UR, Schwab M, Bown N. MYCN amplification and 17q in neuroblastoma: evidence for structural association. Genes Chromosomes Cancer 2001, 30:87-90. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1055>3.0.CO;2-J, 11107180.
11. Lengauer C. Aneuploidy and genetic instability in cancer. Semin Cancer Biol 2005, 15:1. 10.1016/j.semcancer.2004.09.001, 15613282.
12. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004, 432:338-341. 10.1038/nature03099, 15549096.
13. Draviam VM, Xie S, Sorger PK. Chromosome segregation and genomic stability. Curr Opin Genet Dev 2004, 14:120-125. 10.1016/j.gde.2004.02.007, 15196457.
14. Andersen SS. Molecular characteristics of the centrosome. Int Rev Cytol 1999, 187:51-109. 10.1016/S0074-7696(08)62416-X, 10212978.
15. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998, 58:3974-3985.
16. Yamamoto Y, Matsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, Oga A, Naito K, Sasaki K. Biological characteristics in bladder cancer depend on the type of genetic instability. Clin Cancer Res 2006, 12:2752-2758. 10.1158/1078-0432.CCR-05-0805, 16675567.
17. Basto R, Brunk K, Vinadogrova T, Peel N, Franz A, Khodjakov A, Raff JW. Centrosome amplification can initiate tumorigenesis in flies. Cell 2008, 133:1032-1042. 10.1016/j.cell.2008.05.039, 2653712, 18555779.
18. Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL. Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer 2003, 106:661-665. 10.1002/ijc.11251, 12866024.
19. Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 2004, 64:4800-4809. 10.1158/0008-5472.CAN-03-3908, 15256449.
20. Kawamura K, Moriyama M, Shiba N, Ozaki M, Tanaka T, Nojima T, Fujikawa-Yamamoto K, Ikeda R, Suzuki K. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol 2003, 43:505-515. 10.1016/S0302-2838(03)00056-3, 12705995.
21. Jin Y, Stewenius Y, Lindgren D, Frigyesi A, Calcagnile O, Jonson T, Edqvist A, Larsson N, Lundberg LM, Chebil G, et al. Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers. Clin Cancer Res 2007, 13:1703-1712. 10.1158/1078-0432.CCR-06-2705, 17363523.
22. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448. 10.1097/00000478-199812000-00001, 9850170.
23. Nakamura H, Saji H, Idiris A, Kawasaki N, Hosaka M, Ogata A, Saijo T, Kato H. Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens of non-small cell lung cancer is associated with poor survival. Clin Cancer Res 2003, 9:2294-2299.
24. Sauter G, Algaba F, Amin M, Busch C, Cheville J, Gasser T, Grignon DJ, Hostädter F, Lopez-Beltran A, Epstein JI. Non Invasive urothelial neoplasias. WHO classification of non invasive papillary urothelial tumors. World Health organisation classification of tumors. Pathology and gentics: tumors of the urinary sistem and male genital organs 2004, Lyon: IARC, Eble JN, Sauter G, Epstein JI, Sesterhenn I.
25. Nelsen CJ, Kuriyama R, Hirsch B, Negron VC, Lingle WL, Goggin MM, Stanley MW, Albrecht JH. Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem 2005, 280:768-776.
26. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994, 10:231-243. 10.1002/gcc.2870100403, 7522536.
27. Quintyne NJ, Reing JE, Hoffelder DR, Gollin SM, Saunders WS. Spindle multipolarity is prevented by centrosomal clustering. Science 2005, 307:127-129. 10.1126/science.1104905, 15637283.
28. Chandhok NS, Pellman D. A little CIN may cost a lot: revisiting aneuploidy and cancer. Curr Opin Genet Dev 2009, 19:74-81. 10.1016/j.gde.2008.12.004, 19195877.
29. Gergely F, Basto R. Multiple centrosomes: together they stand, divided they fall. Genes Dev 2008, 22:2291-2296. 10.1101/gad.1715208, 2749672, 18765784.
30. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003, 63:1398-1404.
31. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 2008, 180:665-672. 10.1083/jcb.200712029, 2265570, 18283116.
32. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282. 10.1038/nature08136, 2743290, 19506557.
33. Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997, 15:1617-1623. 10.1038/sj.onc.1201311, 9380415.
34. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 2003, 78:323-335. 10.1023/A:1023033708204, 12755491.
35. Jin C, Jin Y, Gisselsson D, Wennerberg J, Wah TS, Stromback B, Kwong YL, Mertens F. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma. Cytogenet Genome Res 2006, 115:99-106. 10.1159/000095228, 17065789.
36. Jin Y, Hoglund M, Jin C, Martins C, Wennerberg J, Akervall J, Mandahl N, Mitelman F, Mertens F. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer 1998, 22:312-320. 10.1002/(SICI)1098-2264(199808)22:4<312::AID-GCC7>3.0.CO;2-Y, 9669669.
37. Debatisse M, Coquelle A, Toledo F, Buttin G. Gene amplification mechanisms: the role of fragile sites. Recent Results Cancer Res 1998, 154:216-226.
38. Kuttler F, Mai S. Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis. Semin Cancer Biol 2007, 17:56-64. 10.1016/j.semcancer.2006.10.007, 17116402.
39. Narayanan V, Mieczkowski PA, Kim HM, Petes TD, Lobachev KS. The pattern of gene amplification is determined by the chromosomal location of hairpin-capped breaks. Cell 2006, 125:1283-1296. 10.1016/j.cell.2006.04.042, 16814715.
40. Singer MJ, Mesner LD, Friedman CL, Trask BJ, Hamlin JL. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks. Proc Natl Acad Sci USA 2000, 97:7921-7926. 10.1073/pnas.130194897, 16646, 10859355.
41. Morales C, Garcia MJ, Ribas M, Miro R, Munoz M, Caldas C, Peinado MA. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Mol Cancer Ther 2009, 8:424-432. 10.1158/1535-7163.MCT-08-0759, 19190117.
42. Valent A, Benard J, Clausse B, Barrois M, Valteau-Couanet D, Terrier-Lacombe MJ, Spengler B, Bernheim A. In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol 2001, 158:1579-1584. 1891958, 11337354.
43. Rebacz B, Larsen TO, Clausen MH, Ronnest MH, Loffler H, Ho AD, Kramer A. Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. Cancer Res 2007, 67:6342-6350. 10.1158/0008-5472.CAN-07-0663, 17616693.